A biotech firm must decide whether to purchase the patent to a new food additive
ID: 2701079 • Letter: A
Question
A biotech firm must decide whether to purchase the patent to a new food additive, a low-cal starch substitute. It is estimated that the funds required to bring the additive to the market can be as high as $50 million or as low as $25 million. The payoff is uncertain as well: The present value of profits could be as high as $500 million or as low as $30 million. The risk free rate is %10, and the standard deviation of rate of return on biotech products is 35%. The patents life is estimated at one year
a) In a worst 2013 case scenario, how much is the patent worth?
b) In a best 2013 case scenario ,how much is the patent worth?
Explanation / Answer
: We need to make a few assumptions to solve this problem. We assume that in one year, the present value of profits will take values of $500M and $30M with equal probability. We further assume that the risk-free discount rate is the appropriate capitalization rate for the firm. In a worst-case scenario, the costs will be $50M. The firm will only adopt the project if NPV > 0, or PV(Benefits) = $500M. The expected net present value is 0.5(500
Related Questions
drjack9650@gmail.com
Navigate
Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.